Spatial biology in CNS drug discovery

Spatial biology techniques like spatial transcriptomics are revealing critical region-specific molecular and gene activity changes in CNS diseases such as Alzheimer's and Parkinson's, which traditional methods miss. These findings provide new biomarkers for early intervention and address the high attrition and slow development rates in CNS drug discovery by focusing on the brain's precise anatomical functional units.

This Wire brief sits within Fusion42's coverage of Drug Discovery, and 1 source has reported it.